nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—Sensitisation—Epirubicin—bone cancer	0.0361	0.0361	CcSEcCtD
Mupirocin—Sensitisation—Doxorubicin—bone cancer	0.0334	0.0334	CcSEcCtD
Mupirocin—Furunculosis—Methotrexate—bone cancer	0.0324	0.0324	CcSEcCtD
Mupirocin—Furunculosis—Epirubicin—bone cancer	0.0303	0.0303	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Methotrexate—bone cancer	0.0299	0.0299	CcSEcCtD
Mupirocin—Tenderness—Cisplatin—bone cancer	0.0288	0.0288	CcSEcCtD
Mupirocin—Furuncle—Methotrexate—bone cancer	0.0281	0.0281	CcSEcCtD
Mupirocin—Furunculosis—Doxorubicin—bone cancer	0.0281	0.0281	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Epirubicin—bone cancer	0.0279	0.0279	CcSEcCtD
Mupirocin—Cellulitis—Cisplatin—bone cancer	0.0276	0.0276	CcSEcCtD
Mupirocin—Furuncle—Epirubicin—bone cancer	0.0263	0.0263	CcSEcCtD
Mupirocin—Pain—Carboplatin—bone cancer	0.0261	0.0261	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Doxorubicin—bone cancer	0.0259	0.0259	CcSEcCtD
Mupirocin—Furuncle—Doxorubicin—bone cancer	0.0243	0.0243	CcSEcCtD
Mupirocin—Stinging—Epirubicin—bone cancer	0.0159	0.0159	CcSEcCtD
Mupirocin—Stinging—Doxorubicin—bone cancer	0.0147	0.0147	CcSEcCtD
Mupirocin—Cellulitis—Epirubicin—bone cancer	0.0142	0.0142	CcSEcCtD
Mupirocin—Cellulitis—Doxorubicin—bone cancer	0.0131	0.0131	CcSEcCtD
Mupirocin—Dermatitis contact—Epirubicin—bone cancer	0.0127	0.0127	CcSEcCtD
Mupirocin—Mouth ulceration—Methotrexate—bone cancer	0.0125	0.0125	CcSEcCtD
Mupirocin—Dermatitis contact—Doxorubicin—bone cancer	0.0118	0.0118	CcSEcCtD
Mupirocin—Mouth ulceration—Epirubicin—bone cancer	0.0117	0.0117	CcSEcCtD
Mupirocin—Immune system disorder—Cisplatin—bone cancer	0.0114	0.0114	CcSEcCtD
Mupirocin—Erythema—Cisplatin—bone cancer	0.011	0.011	CcSEcCtD
Mupirocin—Mouth ulceration—Doxorubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Methotrexate—bone cancer	0.0106	0.0106	CcSEcCtD
Mupirocin—Eczema—Epirubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Epirubicin—bone cancer	0.00992	0.00992	CcSEcCtD
Mupirocin—Eczema—Doxorubicin—bone cancer	0.00964	0.00964	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00928	0.00928	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00918	0.00918	CcSEcCtD
Mupirocin—Anaphylactic shock—Cisplatin—bone cancer	0.00896	0.00896	CcSEcCtD
Mupirocin—Skin disorder—Cisplatin—bone cancer	0.0087	0.0087	CcSEcCtD
Mupirocin—Dry skin—Epirubicin—bone cancer	0.00858	0.00858	CcSEcCtD
Mupirocin—Dry skin—Doxorubicin—bone cancer	0.00794	0.00794	CcSEcCtD
Mupirocin—Pain—Cisplatin—bone cancer	0.00766	0.00766	CcSEcCtD
Mupirocin—Epistaxis—Methotrexate—bone cancer	0.00727	0.00727	CcSEcCtD
Mupirocin—Haemoglobin—Methotrexate—bone cancer	0.00696	0.00696	CcSEcCtD
Mupirocin—Haemorrhage—Methotrexate—bone cancer	0.00692	0.00692	CcSEcCtD
Mupirocin—Pharyngitis—Methotrexate—bone cancer	0.00687	0.00687	CcSEcCtD
Mupirocin—Epistaxis—Epirubicin—bone cancer	0.00681	0.00681	CcSEcCtD
Mupirocin—Hypersensitivity—Cisplatin—bone cancer	0.0066	0.0066	CcSEcCtD
Mupirocin—Haemoglobin—Epirubicin—bone cancer	0.00651	0.00651	CcSEcCtD
Mupirocin—Rhinitis—Epirubicin—bone cancer	0.00649	0.00649	CcSEcCtD
Mupirocin—Haemorrhage—Epirubicin—bone cancer	0.00648	0.00648	CcSEcCtD
Mupirocin—Pharyngitis—Epirubicin—bone cancer	0.00643	0.00643	CcSEcCtD
Mupirocin—Epistaxis—Doxorubicin—bone cancer	0.0063	0.0063	CcSEcCtD
Mupirocin—Immune system disorder—Methotrexate—bone cancer	0.00625	0.00625	CcSEcCtD
Mupirocin—Diarrhoea—Cisplatin—bone cancer	0.00613	0.00613	CcSEcCtD
Mupirocin—Erythema—Methotrexate—bone cancer	0.00603	0.00603	CcSEcCtD
Mupirocin—Haemoglobin—Doxorubicin—bone cancer	0.00602	0.00602	CcSEcCtD
Mupirocin—Rhinitis—Doxorubicin—bone cancer	0.00601	0.00601	CcSEcCtD
Mupirocin—Haemorrhage—Doxorubicin—bone cancer	0.00599	0.00599	CcSEcCtD
Mupirocin—Pharyngitis—Doxorubicin—bone cancer	0.00595	0.00595	CcSEcCtD
Mupirocin—Dysgeusia—Methotrexate—bone cancer	0.0059	0.0059	CcSEcCtD
Mupirocin—Immune system disorder—Epirubicin—bone cancer	0.00585	0.00585	CcSEcCtD
Mupirocin—Rash—Cisplatin—bone cancer	0.00565	0.00565	CcSEcCtD
Mupirocin—Dermatitis—Cisplatin—bone cancer	0.00565	0.00565	CcSEcCtD
Mupirocin—Erythema—Epirubicin—bone cancer	0.00564	0.00564	CcSEcCtD
Mupirocin—Dysgeusia—Epirubicin—bone cancer	0.00552	0.00552	CcSEcCtD
Mupirocin—Immune system disorder—Doxorubicin—bone cancer	0.00541	0.00541	CcSEcCtD
Mupirocin—Nausea—Cisplatin—bone cancer	0.00532	0.00532	CcSEcCtD
Mupirocin—Cough—Methotrexate—bone cancer	0.00526	0.00526	CcSEcCtD
Mupirocin—Erythema—Doxorubicin—bone cancer	0.00522	0.00522	CcSEcCtD
Mupirocin—Dysgeusia—Doxorubicin—bone cancer	0.00511	0.00511	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00509	0.00509	CcSEcCtD
Mupirocin—Cough—Epirubicin—bone cancer	0.00492	0.00492	CcSEcCtD
Mupirocin—Anaphylactic shock—Methotrexate—bone cancer	0.00492	0.00492	CcSEcCtD
Mupirocin—Skin disorder—Methotrexate—bone cancer	0.00478	0.00478	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00477	0.00477	CcSEcCtD
Mupirocin—Dry mouth—Epirubicin—bone cancer	0.0047	0.0047	CcSEcCtD
Mupirocin—Anaphylactic shock—Epirubicin—bone cancer	0.0046	0.0046	CcSEcCtD
Mupirocin—Cough—Doxorubicin—bone cancer	0.00455	0.00455	CcSEcCtD
Mupirocin—Skin disorder—Epirubicin—bone cancer	0.00447	0.00447	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00441	0.00441	CcSEcCtD
Mupirocin—Dry mouth—Doxorubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Mupirocin—Anaphylactic shock—Doxorubicin—bone cancer	0.00426	0.00426	CcSEcCtD
Mupirocin—Pain—Methotrexate—bone cancer	0.00421	0.00421	CcSEcCtD
Mupirocin—Skin disorder—Doxorubicin—bone cancer	0.00414	0.00414	CcSEcCtD
Mupirocin—Gastrointestinal pain—Methotrexate—bone cancer	0.00402	0.00402	CcSEcCtD
Mupirocin—Pain—Epirubicin—bone cancer	0.00394	0.00394	CcSEcCtD
Mupirocin—Urticaria—Methotrexate—bone cancer	0.00391	0.00391	CcSEcCtD
Mupirocin—Abdominal pain—Methotrexate—bone cancer	0.00389	0.00389	CcSEcCtD
Mupirocin—Gastrointestinal pain—Epirubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Mupirocin—Urticaria—Epirubicin—bone cancer	0.00366	0.00366	CcSEcCtD
Mupirocin—Pain—Doxorubicin—bone cancer	0.00364	0.00364	CcSEcCtD
Mupirocin—Abdominal pain—Epirubicin—bone cancer	0.00364	0.00364	CcSEcCtD
Mupirocin—Hypersensitivity—Methotrexate—bone cancer	0.00362	0.00362	CcSEcCtD
Mupirocin—Gastrointestinal pain—Doxorubicin—bone cancer	0.00348	0.00348	CcSEcCtD
Mupirocin—Pruritus—Methotrexate—bone cancer	0.00348	0.00348	CcSEcCtD
Mupirocin—Hypersensitivity—Epirubicin—bone cancer	0.00339	0.00339	CcSEcCtD
Mupirocin—Urticaria—Doxorubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Mupirocin—Abdominal pain—Doxorubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Mupirocin—Diarrhoea—Methotrexate—bone cancer	0.00336	0.00336	CcSEcCtD
Mupirocin—Pruritus—Epirubicin—bone cancer	0.00326	0.00326	CcSEcCtD
Mupirocin—Dizziness—Methotrexate—bone cancer	0.00325	0.00325	CcSEcCtD
Mupirocin—Diarrhoea—Epirubicin—bone cancer	0.00315	0.00315	CcSEcCtD
Mupirocin—Hypersensitivity—Doxorubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Mupirocin—Rash—Methotrexate—bone cancer	0.0031	0.0031	CcSEcCtD
Mupirocin—Dermatitis—Methotrexate—bone cancer	0.0031	0.0031	CcSEcCtD
Mupirocin—Headache—Methotrexate—bone cancer	0.00308	0.00308	CcSEcCtD
Mupirocin—Dizziness—Epirubicin—bone cancer	0.00304	0.00304	CcSEcCtD
Mupirocin—Pruritus—Doxorubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Mupirocin—Nausea—Methotrexate—bone cancer	0.00292	0.00292	CcSEcCtD
Mupirocin—Diarrhoea—Doxorubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Mupirocin—Rash—Epirubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Mupirocin—Dermatitis—Epirubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Mupirocin—Headache—Epirubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Mupirocin—Dizziness—Doxorubicin—bone cancer	0.00282	0.00282	CcSEcCtD
Mupirocin—Nausea—Epirubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Mupirocin—Rash—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Mupirocin—Dermatitis—Doxorubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Mupirocin—Headache—Doxorubicin—bone cancer	0.00267	0.00267	CcSEcCtD
Mupirocin—Nausea—Doxorubicin—bone cancer	0.00253	0.00253	CcSEcCtD
